Valued Customers, We would like to update you on our winter holiday hours of operation:  Our offices will be closed...

STUTTGART, Germany, Nov. 15, 2021  PRNewswire Robert Bosch Venture Capital GmbH, the corporate venture capital company of the Bosch Group, has...

ACMG secondary findings updated list for reporting of secondary findings, for medically actionable genes in clinical exome and genome sequencing. ...

Genomeweb | May 11, 2021 Variantyx, a genetic testing company offering clinical whole-genome sequencing-based assays, is expanding its menu to...

March 15, 2021 Variantyx, a leader in high complexity hereditary disease testing, today announced that they secured $20M in funding...

By Daryl Spinner, PhD, MBA In the realm of genetic testing, insurance payers have been reluctant to recognize that there...

When solving a problem, taking a step back and looking at the big picture is often a wise tactic. In...

Given that genome sequencing has the potential to identify tens of thousands of variants in every patient sample tested, our...

January 26, 2021 Variantyx, a leader in high complexity hereditary disease testing, announced today that it will launch its Genomic Unity®...

By Toni Lewis The use of whole-genome sequencing (WGS) in diagnostic testing brings up the topic of secondary findings or...